India's Concord Biotech up on clearing Kenyan inspection
** Shares of Concord Biotech CONB.NS up 2.8% in
above-average vol
** Biopharma says Kenya's Ministry of Health Pharmacy gave
its Ahmedabad facility good manufacturing practices certificate
** Session's gains help CONB turn positive for the week
** Stock up ~1.5% so far this week
** CONB sees its second most active session of the year,
more than 450,000 shares traded as of 12:30 p.m. IST
** The stock is up ~60% since listing in Aug 2023
(Reporting by Nishit Navin in Begaluru)
((nishit.navin@thomsonreuters.com;))
Recent news on Concord Biotech
See all newsIndia's Concord Biotech rises after board to consider bonus share issue
Brief: Concord Biotech Ltd June-Quarter Consol Net Profit 585.3 Million Rupees
Brief: Concord Biotech Completes PPB (Kenya) And NDA (Uganda) Inspection At Unit-Ii Formulation Facility
Brief: Concord Biotech Completes Anvisa Inspection At Limbasi API Manufacturing Facility
India's Concord Biotech jumps to 4-month high after US FDA drug approval